Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for AIBT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -4.602M
March 31, 2026 -4.280M
December 31, 2025 -3.960M
September 30, 2025 -3.886M
June 30, 2025 -4.208M
March 31, 2025 -3.837M
December 31, 2024 -3.395M
September 30, 2024 -3.359M
June 30, 2024 -2.925M
March 31, 2024 -2.454M
December 31, 2023 -2.028M
September 30, 2023 -1.737M
June 30, 2023 -1.429M
March 31, 2023 -1.194M
December 31, 2022 -0.8913M
September 30, 2022 -0.4512M
June 30, 2022 -0.1592M
March 31, 2022 0.1661M
Date Value
December 31, 2021 0.052M
September 30, 2021 0.2339M
June 30, 2021 -0.1319M
March 31, 2021 -0.0245M
December 31, 2020 -0.0162M
September 30, 2020 0.4836M
June 30, 2020 0.5377M
March 31, 2020 0.6093M
December 31, 2019
September 30, 2019 0.7448M
June 30, 2019 0.7009M
March 31, 2019 0.6616M
December 31, 2018 0.6471M
September 30, 2018 0.6543M
June 30, 2018
March 31, 2018
December 31, 2017 0.5722M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
CS Diagnostics Corp. 499.47M
GeneDx Holdings Corp. 244.22M
Ayujoy Herbals Ltd. --
Arrowhead Pharmaceuticals, Inc. 465.53M
Oncolytics Biotech, Inc. -6.167M

Shareholders Equity (Quarterly) Related Metrics